BrainsWay Ltd. (BWAY)
TASE
Real-time Data
06:59 AM
Day's Range
4,220.0052 wk Range
2,391.00Overview - BWAY - BrainsWay Ltd.
Key Statistics
Valuation
Enterprise Value
174.39B
P/E (Trailing)
‪63.14‬
P/E (Forward)
‪88.91‬
PEG Ratio
‪0.63‬
Price / Sales (TTM)
‪28.84‬
Price / Book
‪2,130.56‬
EV / EBITDA
‪199.43‬
Profitability
Gross Margin
‪75.17%‬
Profit Margin
‪15.55%‬
Operating Margin
‪13.97%‬
Return on Assets
‪4.04%‬
Return on Equity
‪12.81%‬
Ownership
Shares Outstanding
40.03M
Float
23.19M
Held by Insiders
‪9.50%‬
Held by Institutions
‪10.70%‬
Price stats
Beta
‪0.09‬
50-Day Avg
‪4,589.74‬
200-Day Avg
‪4,016.95‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - BWAY - BrainsWay Ltd.
Peers - BWAY - BrainsWay Ltd.
Peer Comparison
Compared with companies in Medical Devices listed on TASE.
Profile Summary - BWAY - BrainsWay Ltd.
About
BrainsWay Ltd. is a healthcare company at the forefront of developing advanced medical technology for the treatment of brain health disorders. Specializing in Deep Transcranial Magnetic Stimulation (Deep TMS), BrainsWay aims to offer effective, non-invasive treatment options for conditions such as depression,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
